Billionaire Profile
L
Global Rank
#349

Image: see below | Public domain | via Wikimedia Commons

Li Xiting

CEO, Medical devices
SINGAPORE
Real-Time Net Worth
$9.877B
Estimated based on Medical devices stock value as of April 21, 2026
+0.8% (24h)
Age
75
Source
Medical devices
Industry
healthcare
Citizenship
SINGAPORE

Biography

Li Xiting is a Chinese-born Singaporean billionaire, co-founder, and chairman of Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a leading medical device manufacturer. His estimated net worth is $11.1 billion. Born in China, he earned a degree in low-temperature physics and worked as a researcher before venturing into entrepreneurship. Li's career highlights include founding Mindray in 1991, leading its expansion, and guiding the company's public listing. His wealth source is primarily from his stake in the medical device industry. He is known for his philanthropy and commitment to innovation.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/21/2026

Wealth Over Time

In-Depth Profile

Early Life

Li Xiting was born in 1951 in Dangshan County, Anhui Province, China. He grew up in a rural area during a time of economic hardship. At age 18, he joined the People's Liberation Army. He later pursued higher education, graduating with a bachelor's degree in low-temperature physics from the University of Science and Technology of China in 1976.

Rise to Success

After graduation, Li worked as a researcher at various institutions before joining Anke Technology in 1987. In 1991, Li co-founded Mindray with seven colleagues. Mindray started by producing affordable medical monitors. Under Li's leadership, Mindray expanded its product line and achieved international certifications. The company went public on the New York Stock Exchange in 2006, and later relisted on the Shenzhen Stock Exchange. The COVID-19 pandemic significantly increased the demand for Mindray's medical equipment, boosting Li's wealth.

Key Business Strategies

Li's success is attributed to Mindray's commitment to innovation and quality. The company invests a significant portion of its revenue in research and development. Mindray also expanded through strategic acquisitions, such as Datascope in 2008. Li emphasized teamwork and determination as key factors in his success.

Philanthropy

Li is known for his philanthropy, particularly in education. He has donated millions to his alma mater, the University of Science and Technology of China (USTC). In 2024, he established a fund to support talent cultivation and scientific research at USTC. Mindray, under Li's leadership, also donated medical devices during the COVID-19 pandemic.

Career Milestones

1976

Graduated

Graduated from the University of Science and Technology of China with a degree in low-temperature physics.

1991

Co-founded Mindray

Co-founded Mindray Bio-Medical Electronics Co., Ltd. in Shenzhen, China.

2006

Mindray IPO

Led Mindray's initial public offering on the New York Stock Exchange.

2018

Became a Singaporean Citizen

Became a naturalized citizen of Singapore.

Philanthropy & Social Impact

Education

Li Xiting Fund

$16.8M

Established the Li Xiting Fund at the University of Science and Technology of China (USTC) to support talent cultivation and scientific research.

Education

Donation to USTC

$0.67M

Donated to his alma mater, the University of Science and Technology of China, to support academic development and talent cultivation.

Healthcare

COVID-19 Relief

$4.6M

Mindray, chaired by Li Xiting, donated medical devices to hospitals worldwide during the COVID-19 pandemic.

Business Philosophy & Leadership

Notable Quotes

"As an alumnus of USTC, I feel obliged to give (a) donation to my alma mater for her cultivation on me when I am capable to do so."

"Building a worldleading smart supply chain."

Leadership Principles

Commitment to Innovation

Investing in research and development to bring advanced medical technology to the global market.

Teamwork and Determination

Emphasizing collaboration and perseverance as key factors in achieving success.